Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer

被引:10
作者
Akiyama, Y
Kuzushima, K
Tsurumi, T
Yamaguchi, K
机构
[1] Natl Canc Ctr, Res Inst, Chuo Ku, Div Growth Factor, Tokyo 104, Japan
[2] Shizuoka Canc Ctr, Inst Res, Div Immunotherapy, Shizuoka 4118777, Japan
[3] Aichi Canc Ctr, Res Inst, Div Immunol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[4] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
关键词
CMV pp65 matrix protein; cytotoxic T cell; HLA-A24/CMVpp65; tetramer; INF-gamma production; anti-CMV antibody;
D O I
10.1016/j.imlet.2004.07.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Developing precise and efficient methods of monitoring immune responses against cytomegalovirus (CMV) infection in immunocompromised transplantation patients is important. With the aim of optimizing the monitoring strategy, an HLA-A24-CMVpp65 tetramer-based analysis of CMVpp65 peptide-specific CTL lines was performed. Previously, the HLA-A24-restricted CTL epitope of CMVpp65 matrix protein was identified (QYDPVAALF aa 341-349). In the present study, CMVpp65 (aa 341-349) peptide- specific CTL lines were obtained from PBLs of 12 HLA-A24(+) healthy donors by two stimulations with peptide-pulsed dendritic cells (DC). Among 12 CTL lines, 9 showed HLA-A*2402-CMVpp65 tetramer staining, which was found to be strongly co-related to the amount of IFN-gamma produced by CMVpp65 peptider-estimulated CTL lines (r = 0.943, P < 0.001). These results suggested that HLA-A*2402-CMVpp65 tetramer staining was an efficient way to monitor immune responses against CMV infection in HLA-A24(+) immunocompromised hosts. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 28 条
[1]   Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus [J].
Akiyama, Y ;
Maruyama, K ;
Mochizuki, T ;
Sasaki, K ;
Takaue, Y ;
Yamaguchi, K .
IMMUNOLOGY LETTERS, 2002, 83 (01) :21-30
[2]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[3]   HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function [J].
Appay, V ;
Nixon, DF ;
Donahoe, SM ;
Gillespie, GMA ;
Dong, T ;
King, A ;
Ogg, GS ;
Spiegel, HML ;
Conlon, C ;
Spina, CA ;
Havlir, DV ;
Richman, DD ;
Waters, A ;
Easterbrook, P ;
McMichael, AJ ;
Rowland-Jones, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :63-75
[4]   Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants [J].
Aubert, G ;
Hassan-Walker, AF ;
Madrigal, JA ;
Emery, VC ;
Morte, C ;
Grace, S ;
Koh, MBC ;
Potter, M ;
Prentice, HG ;
Dodi, IA ;
Travers, PJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :955-963
[5]   HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy [J].
Chen, FE ;
Aubert, G ;
Travers, P ;
Dodi, IA ;
Madrigal, JA .
CYTOTHERAPY, 2002, 4 (01) :41-48
[6]   CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection [J].
Chen, G ;
Shankar, P ;
Lange, C ;
Valdez, H ;
Skolnik, PR ;
Wu, LJ ;
Manjunath, N ;
Lieberman, J .
BLOOD, 2001, 98 (01) :156-164
[7]   Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide [J].
Einsele, H ;
Rauser, G ;
Grigoleit, U ;
Hebart, H ;
Sinzger, C ;
Riegler, S ;
Jahn, G .
CYTOTHERAPY, 2002, 4 (01) :49-54
[8]   Characterization of CMVpp65-specific CD8+T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants [J].
Engstrand, M ;
Tournay, C ;
Peyrat, MA ;
Eriksson, BM ;
Wadström, J ;
Wirgart, BZ ;
Romagné, F ;
Bonneville, M ;
Tötterman, TH ;
Korsgren, O .
TRANSPLANTATION, 2000, 69 (11) :2243-2250
[9]   Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics [J].
Faint, JM ;
Annels, NE ;
Curnow, SJ ;
Shields, P ;
Pilling, D ;
Hislop, AD ;
Wu, LJ ;
Akbar, AN ;
Buckley, CD ;
Moss, PAH ;
Adams, DH ;
Rickinson, AB ;
Salmon, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :212-220
[10]  
FORMAN SJ, 1994, BLOOD, V83, P2392